Biotechnology startups operate in one of the most capital-intensive and highly regulated environments in the global economy. From early-stage research to clinical trials and regulatory approvals, companies must manage complex financial operations long before they generate revenue. Because of this, … Continue reading Why Biotech Startups Need Fractional CFO Infrastructure Before Their Next Capital Raise